Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | AURKA | O14965 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.30 |
| ▸ | PDE2A | O00408 | 1/20 | 0.30 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17445635 | 0.84 | MAPT (0.33) | — | |
| SCHEMBL17445632 | 0.82 | LMNA (0.43) | — | |
| SCHEMBL14280986 | 0.81 | CACNA1H (0.43) | CRHR1CACNA1HAURKAKDRAURKB | |
| SCHEMBL17445640 | 0.79 | NQO2 (0.36) | CRHR1CACNA1HAURKAKDRAURKB | |
| SCHEMBL17445638 | 0.79 | CYP11B1 (0.31) | — | |
| SCHEMBL14280983 | 0.76 | AURKA (0.36) | CRHR1CACNA1HAURKAKDRAURKB | |
| SCHEMBL20049332 | 0.66 | HPGD (0.34) | — | |
| SCHEMBL5942469 | 0.63 | AURKA (0.42) | CRHR1MEN1KMT2AAURKAKDR | |
| SCHEMBL14885781 | 0.63 | ACHE (0.46) | ALDH1A1AURKAKDRAURKB | |
| SCHEMBL30908374 | 0.62 | AR (0.42) | MEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11678571-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | IDEMITSU KOSAN CO., LTD. (JP) | 2023-06-13 | — | — | US | disclosed |
| US-9960360-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-01 | — | — | US | disclosed |
| US-20180090685-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-03-29 | — | — | US | disclosed |
| US-20180040828-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-08 | — | — | US | disclosed |
| US-20160020403-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11678571-B2 | Organic electroluminescent device using aryl amine derivative containing heterocycle | RPS17, RPS19, CDK17 | CRHR1 2524/4885CACNA1H 3912/4885MEN1 3396/4885 |
| US-20180090685-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | SLC18A1, SLC18A2, AOC2 | CRHR1 3821/4885CACNA1H 1984/4885MEN1 2762/4885 |
| US-20180040828-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | SLC18A1, SLC18A2, AOC2 | CRHR1 3821/4885CACNA1H 1984/4885MEN1 2762/4885 |
| US-20160020403-A1 | ORGANIC ELECTROLUMINESCENT DEVICE USING ARYL AMINE DERIVATIVE CONTAINING HETEROCYCLE | SLC18A1, SLC18A2, AOC2 | CRHR1 3821/4885CACNA1H 1984/4885MEN1 2762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.